TRIMETHYLANGELICIN AS CFTR CORRECTOR IN BRONCHIAL EPITHELIAL CELLS

• 收藏
• 分享

专利权人:

Roberto Gambari;Valeria Casavola;Giulio Cabrini

发明人:

Giulio Cabrini,Valeria Casavola,Roberto Gambari

申请号：

US14125109

公开号：

US20150290167A1

申请日:

2012.06.13

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The invention relates to the use of 4,6,4′-trimethylangelicin (TMA) and structural analogues thereof to prepare a medicament for the treatment of cystic fibrosis with the primary objective of correcting the defective CFTR in a sub-group of cystic fibrosis patients consisting of patients carrying the F508de1-CFTR mutation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/